• No results found

Identifying Potential biomarkers of insulin sensitivity and insulin resistance in obese patients

N/A
N/A
Protected

Academic year: 2021

Share "Identifying Potential biomarkers of insulin sensitivity and insulin resistance in obese patients"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Identifying Potential biomarkers of insulin sensitivity and insulin resistance in obese patients Al-Sulaiti, Haya

DOI:

10.33612/diss.122707627

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Al-Sulaiti, H. (2020). Identifying Potential biomarkers of insulin sensitivity and insulin resistance in obese patients. University of Groningen. https://doi.org/10.33612/diss.122707627

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions belonging to this thesis

Identifying Potential biomarkers of

insulin sensitivity and insulin resistance

in obese patients

By Haya Alsulaiti

1. Rapidly changing lifestyle, accompanied by consumption of excess energy in the form of a calorie-rich high-fat diet, lower voluntary activity, and increased exposure to environmental pollutants, have led to an exponential rise in noncommunicable metabolic diseases (this thesis).

2. Obesity and diabetes are part of a life-threatening legacy (Stephen Furst).

3. Obesity is associated with increased incidents of diabetes, but some obese individuals are seemingly protected from obesity-associated comorbidities (this thesis).

4. Our bodies carry the secret of our own salvation. If we understand what makes one survive an inevitable sickness, we could help the less fortunate ones (Mohamed Elrayess).

5. Dietary fat, whether saturated or not, is not a cause of obesity, heart disease or any other chronic disease of civilization (Andrew Wei)

6. Issues like obesity do, as you well know, have a knock-on effect to diabetes. So we all are better off if we invest early in prevention (Jacinda Ardern).

7. Prevention is better than intervention (Desiderius Erasmus).

8. If we don't somehow stem the tide of childhood obesity, we're going to have a huge problem. (Lance Armstrong).

9. We must pay greater attention to keeping our bodies and minds healthy and able to heal. Yet we are making it difficult for our defenses to work. We allow things to be sold that should not be called food. Many have no nutritive value and lead to obesity, salt imbalance, and allergies (David Suzuki)

10. If you play hard and work hard you will have nothing to worry about it (Haya Al-Sulaiti).

Referenties

GERELATEERDE DOCUMENTEN

In contrast to the ∆BMI, the ∆FPG was different between both groups after 18 months, with an increase in FPG in the daily clinical practice group. Next to

Data were extracted on the study design, sample size, calendar time of data collection, mean age of participants, ethnicity, criteria used to determine IR (method and cut-off

Insulin signalling, insulin-mediated expression of GLUT-4 and FAT/CD36 at the cell membrane and intramyocellular triglyceride content were determined in skeletal muscle

The purpose of this study was to evaluate the long-term (18 months) eff ect of a once-only 30-day VLCD (Modifast®, 450 kCal/day) on body weight and glycaemic control in obese type

Considerable weight loss not only restores basal EGP to normal levels but also greatly enhances peripheral insulin sensitivity, especially insulin-stimulated glucose

De volgende conclusies met betrekking tot het laagcalorisch dieet in obese DM2 kunnen worden getrokken: 1) het is veilig om een VLCD aan deze groep patiënten te geven;

Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose lowering therapies

De snelle daling van de bloedsuikerwaarden na het starten van een zeer laag- calorisch dieet in obese patiënten met type 2 diabetes mellitus berust op een